Esperion Therapeutics Inc (NAS:ESPR)
$ 2.12 0.12 (6%) Market Cap: 415.99 Mil Enterprise Value: 472.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Q4 2023 Esperion Therapeutics Inc Earnings Call Transcript

Feb 27, 2024 / 01:00PM GMT
Release Date Price: $2.9 (+10.27%)
Operator

Good morning, ladies and gentlemen. Thank you for standing by and welcome to Esperion's fourth-quarter 2023 earnings conference call.(Operator Instructions) Please be advised that today's conference call may be recorded. I would now like to hand the conference over to Alexis Callahan, Head of Investor Relations. Please go ahead, Alexis.

Thank you, operator.

Alexis Callahan
Esperion Therapeutics, Inc. - IR

Good morning, and welcome to Esperion's fourth quarter and full year 2023 earnings conference call. With us today are Sheldon Koenig, President and CEO; and Ben Halladay, CFO, and other members of the executive team will be available for Q&A following our prepared remarks, we issued a press release earlier this morning detailing the content of today's call.

A copy can be found on the Investor page of our website, together with a copy of the presentation that we will also be referencing. I want to remind callers that the information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot